FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2904226019> ?p ?o ?g. }

• W2904226019 endingPage "e0208979" @default.
• W2904226019 startingPage "e0208979" @default.
• W2904226019 abstract "LIM kinases are located at a strategic crossroad, downstream of several signaling pathways and upstream of effectors such as microtubules and the actin cytoskeleton. Cofilin is the only LIM kinases substrate that is well described to date, and its phosphorylation on serine 3 by LIM kinases controls cofilin actin-severing activity. Consequently, LIM kinases inhibition leads to actin cytoskeleton disorganization and blockade of cell motility, which makes this strategy attractive in anticancer treatments. LIMK has also been reported to be involved in pathways that are deregulated in hematologic malignancies, with little information regarding cofilin phosphorylation status. We have used proteomic approaches to investigate quantitatively and in detail the phosphorylation status of cofilin in myeloid tumor cell lines of murine and human origin. Our results show that under standard conditions, only a small fraction (10 to 30% depending on the cell line) of cofilin is phosphorylated (including serine 3 phosphorylation). In addition, after a pharmacological inhibition of LIM kinases, a residual cofilin phosphorylation is observed on serine 3. Interestingly, this 2D gel based proteomic study identified new phosphorylation sites on cofilin, such as threonine 63, tyrosine 82 and serine 108." @default.
• W2904226019 created "2018-12-22" @default.
• W2904226019 creator A5003096040 @default.
• W2904226019 creator A5032915990 @default.
• W2904226019 creator A5035841414 @default.
• W2904226019 creator A5054233219 @default.
• W2904226019 creator A5064481807 @default.
• W2904226019 creator A5066877921 @default.
• W2904226019 creator A5070083140 @default.
• W2904226019 creator A5074951005 @default.
• W2904226019 creator A5085208614 @default.
• W2904226019 date "2018-12-14" @default.
• W2904226019 modified "2023-10-15" @default.
• W2904226019 title "A quantitative proteomic analysis of cofilin phosphorylation in myeloid cells and its modulation using the LIM kinase inhibitor Pyr1" @default.
• W2904226019 cites W1562714541 @default.
• W2904226019 cites W1587423226 @default.
• W2904226019 cites W1640813462 @default.
• W2904226019 cites W1933768295 @default.
• W2904226019 cites W1970100686 @default.
• W2904226019 cites W1976100793 @default.
• W2904226019 cites W1976768672 @default.
• W2904226019 cites W1980148753 @default.
• W2904226019 cites W1992497040 @default.
• W2904226019 cites W1996583326 @default.
• W2904226019 cites W2002060477 @default.
• W2904226019 cites W2002294758 @default.
• W2904226019 cites W2003481405 @default.
• W2904226019 cites W2005095805 @default.
• W2904226019 cites W2014089759 @default.
• W2904226019 cites W2016022557 @default.
• W2904226019 cites W2018571987 @default.
• W2904226019 cites W2047484835 @default.
• W2904226019 cites W2059350210 @default.
• W2904226019 cites W2060823872 @default.
• W2904226019 cites W2064347745 @default.
• W2904226019 cites W2068700938 @default.
• W2904226019 cites W2075850504 @default.
• W2904226019 cites W2076875064 @default.
• W2904226019 cites W2078841139 @default.
• W2904226019 cites W2089813112 @default.
• W2904226019 cites W2092002157 @default.
• W2904226019 cites W2093855538 @default.
• W2904226019 cites W2100295401 @default.
• W2904226019 cites W2101629470 @default.
• W2904226019 cites W2115596383 @default.
• W2904226019 cites W2122608403 @default.
• W2904226019 cites W2122693202 @default.
• W2904226019 cites W2126139729 @default.
• W2904226019 cites W2126818822 @default.
• W2904226019 cites W2128635872 @default.
• W2904226019 cites W2135174117 @default.
• W2904226019 cites W2135581618 @default.
• W2904226019 cites W2137828907 @default.
• W2904226019 cites W2138394833 @default.
• W2904226019 cites W2142612272 @default.
• W2904226019 cites W2144600779 @default.
• W2904226019 cites W2154654825 @default.
• W2904226019 cites W2158052587 @default.
• W2904226019 cites W2159375452 @default.
• W2904226019 cites W2200361686 @default.
• W2904226019 cites W2306452339 @default.
• W2904226019 cites W2342485854 @default.
• W2904226019 cites W2400781654 @default.
• W2904226019 cites W2517440376 @default.
• W2904226019 cites W2604317589 @default.
• W2904226019 cites W2730651489 @default.
• W2904226019 cites W2809324503 @default.
• W2904226019 cites W3101436703 @default.
• W2904226019 cites W3104340513 @default.
• W2904226019 cites W4234586755 @default.
• W2904226019 cites W4293247451 @default.
• W2904226019 cites W51614962 @default.
• W2904226019 doi "https://doi.org/10.1371/journal.pone.0208979" @default.
• W2904226019 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6294390" @default.
• W2904226019 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30550596" @default.
• W2904226019 hasPublicationYear "2018" @default.
• W2904226019 type Work @default.
• W2904226019 sameAs 2904226019 @default.
• W2904226019 citedByCount "9" @default.
• W2904226019 countsByYear W29042260192019 @default.
• W2904226019 countsByYear W29042260192020 @default.
• W2904226019 countsByYear W29042260192021 @default.
• W2904226019 countsByYear W29042260192022 @default.
• W2904226019 crossrefType "journal-article" @default.
• W2904226019 hasAuthorship W2904226019A5003096040 @default.
• W2904226019 hasAuthorship W2904226019A5032915990 @default.
• W2904226019 hasAuthorship W2904226019A5035841414 @default.
• W2904226019 hasAuthorship W2904226019A5054233219 @default.
• W2904226019 hasAuthorship W2904226019A5064481807 @default.
• W2904226019 hasAuthorship W2904226019A5066877921 @default.
• W2904226019 hasAuthorship W2904226019A5070083140 @default.
• W2904226019 hasAuthorship W2904226019A5074951005 @default.
• W2904226019 hasAuthorship W2904226019A5085208614 @default.
• W2904226019 hasBestOaLocation W29042260191 @default.
• W2904226019 hasConcept C11960822 @default.
• W2904226019 hasConcept C142669718 @default.
• W2904226019 hasConcept C1491633281 @default.
• W2904226019 hasConcept C184235292 @default.

• next